Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized,Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

NCT04241315 is registered in ClinicalTrials.gov with On Target Laboratories, LLC as lead sponsor.

NCT NCT04241315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04241315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized,Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
Lead sponsor
On Target Laboratories, LLC
Phase
Phase 3
Overall status
Completed
Start date
March 26, 2020
Completion date
November 1, 2021
Enrollment
112 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, lung neoplasms